No Prescription |
 |
 | ||
|
COSART Losacar |
|
| ||
No Prescription » Prescription Drugs 5 » COSART Losacar Losartan is used alone or in combination with other medications to treat high blood pressure. Losartan is in a class of medications called angiotensin II receptor antagonists. It works by blocking the action of certain chemicals that tighten the blood vessels so blood flows more smoothly.Losartan comes as a tablet to take by mouth. It is usually taken once or twice a day with or without food. To help you remember to take losartan take it around the same time every day. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Take losartan exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.Losartan controls high blood pressure but does not cure it. Continue to take losartan even if you feel well. Do not stop taking losartan without talking to your doctor. Buy COSART Losacar and other Prescription Drugs 5 products online at Medstore. Buy Online at Medstore - Click Here!
About COSART Losacar: Product Type: Prescription Drugs 5 COSART ( Losacar Cozaar Generic Losartan ) COSART (Losacar Cozaar Generic Losartan) Losacar Cozaar Generic Losartan 25mg Tabs 30 (3 x 10) 50mg Tabs Losacar Cozaar Generic Losartan COSART
View more Prescription Drugs 5 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
